KHON2

Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGM

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...
Nasdaq

Medtronic Announces Real-World Data on InPen™ and Extended Infusion Set* Pivotal Trial Data at the American Diabetes Association 81st Scientific Sessions

DUBLIN, June 23, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 81th scientific ...
Nasdaq

MDT Stock Gains From FDA Approval for Its InPen App

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) clearance for its new InPen app, which features missed meal dose detection. This latest FDA clearance should pave the way for ...
FierceBiotech

Medtronic scores FDA clearance for smart insulin pen app aimed at multiple daily injections

With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete diabetes management system aimed at people taking multiple insulin injections per ...
WBAL

FDA Approves of First-of-Its-Kind Insulin Device That Gives Hope for ‘Artificial Pancreas’

(WASHINGTON) — The U.S. Food and Drug Administration approved a first-of-its-kind insulin device today designed to automatically deliver insulin for type 1 diabetics. The device has many in the ...
Business Wire

Insulin Pumps Segment Projected to Lead Growth in Global Insulin Delivery Devices Market to 2028, with a CAGR of 8.5% by 2028 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Insulin Delivery Devices Market by Type (Insulin Pens [Reusable, Disposable], Insulin Pumps (Tethered, Tubeless), Insulin ...